ArticleEuropean radiology2026
Deep learning image reconstruction for 50-keV virtual monoenergetic dual-energy CT of the thyroid: a prospective "dual-low" dose study.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDual-energy CT (DECT) at 50 keV increases iodine attenuation but exponentially amplifies image noise. The feasibility of using deep learning image reconstruction (DLIR) to counteract this noise under a "dual-low" (low-radiation and low-contrast medium) thyroid CT protocol remains underexplored. To investigate the performance of a dual-low DECT protocol combined with DLIR in contrast-enhanced thyroid CT compared with a standard-dose protocol using adaptive statistical iterative reconstruction-Veo (ASIR-V). MATERIALS AND
methodsIn this prospective study (August-December 2025), patients were randomly assigned to a standard-dose group (120 kVp, 1.0 mL/kg iodine, ASIR-V 50%) or a dual-low dose group (DECT, 0.6 mL/kg iodine). Dual-low spectral data were reconstructed into 50-keV virtual monoenergetic images using ASIR-V 50%, low-strength DLIR (DLIR-L), and high-strength DLIR (DLIR-H). Objective metrics (CT attenuation, image noise, contrast-to-noise ratio, edge rise slope (ERS), noise power spectrum) and subjective 5-point Likert scores were compared using independent-samples t-tests, paired t-tests, Mann-Whitney U tests, and Wilcoxon signed-rank tests.
resultsSixty-four patients (mean age, 48.6 years ± 12.2; 49 women) were evaluated (32 per group). The dual-low group achieved a 61% reduction in effective radiation dose (0.36 mSv ± 0.05 vs 0.93 mSv ± 0.22; p < 0.001) and a 20% reduction in iodine intake (11.7 g ± 1.8 vs 14.6 g ± 4.0; p < 0.001). Despite these reductions, DLIR-H demonstrated significantly lower image noise (10.9 HU ± 2.0 vs 15.3 HU ± 2.5; p < 0.001) and steeper ERS than the standard-dose protocol. DLIR-H preserved a natural noise texture comparable to ASIR-V. Subjectively, DLIR-H scored near-perfectly in overall image quality (5.0 ± 0.2), significantly outperforming the standard protocol (4.6 ± 0.5; p < 0.001).
conclusionCombining 50-keV virtual monoenergetic imaging and DLIR-H facilitates a dual-low scanning strategy for thyroid CT, yielding superior objective and subjective image quality while substantially reducing radiation and iodine burdens. KEY POINTS: Question How can we counteract the severe noise of 50-keV dual-energy CT to enable a low-radiation, low-contrast scanning protocol for thyroid imaging? Findings Deep learning reconstruction at 50-keV significantly suppressed noise, maintaining edge sharpness and diagnostic confidence while reducing radiation by 61% and iodine by 20%. Clinical relevance This dual-low strategy provides a safer imaging alternative that preserves diagnostic quality. It is highly beneficial for vulnerable patients requiring lifelong CT surveillance or those with borderline renal function amid global contrast media shortages.
Indexed as
Identifiers
42714621What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.